About the Product

Description


Nimoplit Injection contains Nimodipine (10mg), a calcium channel blocker primarily used to prevent and treat cerebral vasospasm following subarachnoid hemorrhage (SAH). By relaxing and widening blood vessels in the brain, it enhances cerebral blood flow and reduces the risk of secondary brain damage due to reduced oxygen supply.

Nimodipine is highly effective in neurology and is often used in critical care settings to improve neurological recovery after a brain hemorrhage. It also exhibits potential benefits in preventing stroke-related complications and protecting brain cells from ischemic damage.

Administered intravenously, Polyflip B Injection is recommended for short-term use in intensive care settings, where close monitoring of blood pressure and heart function is essential. It plays a crucial role in improving patient outcomes by ensuring adequate oxygenation of brain tissues.

May cause low blood pressure, dizziness, headache, nausea, flushing, and slow heart rate.

Used for the prevention and treatment of cerebral vasospasm in patients with subarachnoid hemorrhage (SAH).

Administer under strict medical supervision, with continuous monitoring of blood pressure and heart function.

Store at 15°C to 30°C, away from light. Do not refrigerate or freeze.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Nimodipine 10mg Injection in the PCD pharma franchise market?

Nimodipine 10mg Injection has demand in the neurology, critical care, neurosurgery, and hospital care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on specialty injectable and neurocare portfolios.

Why should medical distributors include Nimodipine 10mg Injection in their product range?

Medical distributors and agencies can benefit from consistent demand for neurological and critical care management under specialist medical supervision. Nimodipine 10mg is a calcium channel blocker with a selective action on cerebral blood vessels Commonly used in the management of subarachnoid hemorrhage and the prevention of cerebral vasospasm following aneurysmal bleeding, as prescribed by neurologists and neurosurgeons Helps improve cerebral blood flow and supports neurological care in hospitalized patients Injectable formulation is primarily used in intensive care units, neurology departments, and neurosurgical settings Widely utilized by neurologists, neurosurgeons, intensivists, and critical care specialists This strengthens a comprehensive neurocare and hospital injectable portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this injection?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Nimodipine 10mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from demand in specialty hospital segments, institutional orders, reliable supply chain support, and attractive margins in the neurology and critical care market.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality product ranges, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.